Simplified Report on Changes in Equity
Company Name: Xizang Duorui Pharmaceutical Co., Ltd. Stock Listing Location: Shenzhen Stock Exchange Stock Abbreviation: Duorui Pharmaceutical Stock Code: 301075
Information Disclosure Obligor: Xizang Jiakang Times Technology Development Co., Ltd. Address/Contact Address: Warehouse No. 1006, 1st Floor, Building 1, Biomedical Park, Area A, Economic Development Zone, Qamdo City, Tibet Autonomous Region
Information Disclosure Obligor's Related Party: Zhoushan Qingchang Enterprise Management Partnership (Limited Partnership) Address/Contact Address: Room 305-64503, Enterprise Service Center, China (Zhejiang) Pilot Free Trade Zone, Zhoushan Port Comprehensive Bonded Zone, Beichan Township, Dinghai District, Zhoushan City, Zhejiang Province, China
Nature of Equity Change: Reduction in shares (tender offer, reduction in shareholding percentage) Date of Signing: February 2026
Statement of Information Disclosure Obligor
I. This report is prepared in accordance with the "Company Law of the People's Republic of China," the "Securities Law of the People's Republic of China," the "Administrative Measures for the Takeover of Listed Companies," and the "Format Rules for Information Disclosure of Publicly Issued Securities Companies No. 15 – Report on Changes in Equity," and other relevant laws, regulations, and departmental rules.
II. The information disclosure obligor has obtained the necessary authorization and approval to sign this report, and its actions do not violate any clauses of its articles of association or internal rules, nor do they conflict with them.
III. In accordance with the provisions of the "Securities Law of the People's Republic of China," the "Administrative Measures for the Takeover of Listed Companies," and the "Format Rules for Information Disclosure of Publicly Issued Securities Companies No. 15 – Report on Changes in Equity," this report fully discloses the changes in the equity interests of the information disclosure obligor in Xizang Duorui Pharmaceutical Co., Ltd. As of the date of signing this report, apart from the shareholding information disclosed herein, the information disclosure obligor has not increased or decreased its equity interests in Xizang Duorui Pharmaceutical Co., Ltd. through any other means.
IV. The current equity change is based on the information contained in this report. Other than the information disclosure obligor, no other person has been entrusted or authorized to provide information not listed in this report or to make any explanations or clarifications regarding this report.
V. The information disclosure obligor hereby undertakes that this report contains no false records, misleading statements, or material omissions, and assumes individual and joint legal liability for its truthfulness, accuracy, and completeness.
Table of Contents
Section 1: Definitions ... 3 Section 2: Introduction to the Information Disclosure Obligor ... 4 Section 3: Purpose of the Current Equity Change ... 7 Section 4: Method of the Current Equity Change ... 8 Section 5: Situation of Trading Shares of the Listed Company in the Past 6 Months ... 11 Section 6: Other Major Matters ... 12 Section 7: Documents for Inspection ... 13 Statement of the Information Disclosure Obligor ... 14 Appendix ... 16
Section 1: Definitions
In this report, unless otherwise stated, the following terms and abbreviations have the meanings set forth below: